Oral Polio Vaccines Market
1 Study Coverage
1.1 Oral Polio Vaccines (OPV) Product Introduction
1.2 Market by Type
1.2.1 Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Trivalent OPV
1.2.3 Bivalent OPV
1.3 Market by Application
1.3.1 Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Polio Vaccines (OPV) Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Polio Vaccines (OPV) Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Polio Vaccines (OPV) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Polio Vaccines (OPV) Sales by Region
2.4.1 Global Oral Polio Vaccines (OPV) Sales by Region (2017-2022)
2.4.2 Global Sales Oral Polio Vaccines (OPV) by Region (2023-2028)
2.5 Global Oral Polio Vaccines (OPV) Revenue by Region
2.5.1 Global Oral Polio Vaccines (OPV) Revenue by Region (2017-2022)
2.5.2 Global Oral Polio Vaccines (OPV) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Polio Vaccines (OPV) Sales by Manufacturers
3.1.1 Global Top Oral Polio Vaccines (OPV) Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Polio Vaccines (OPV) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Polio Vaccines (OPV) in 2021
3.2 Global Oral Polio Vaccines (OPV) Revenue by Manufacturers
3.2.1 Global Oral Polio Vaccines (OPV) Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Polio Vaccines (OPV) Revenue in 2021
3.3 Global Oral Polio Vaccines (OPV) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Polio Vaccines (OPV) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Polio Vaccines (OPV) Sales by Type
4.1.1 Global Oral Polio Vaccines (OPV) Historical Sales by Type (2017-2022)
4.1.2 Global Oral Polio Vaccines (OPV) Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
4.2 Global Oral Polio Vaccines (OPV) Revenue by Type
4.2.1 Global Oral Polio Vaccines (OPV) Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Polio Vaccines (OPV) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
4.3 Global Oral Polio Vaccines (OPV) Price by Type
4.3.1 Global Oral Polio Vaccines (OPV) Price by Type (2017-2022)
4.3.2 Global Oral Polio Vaccines (OPV) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Polio Vaccines (OPV) Sales by Application
5.1.1 Global Oral Polio Vaccines (OPV) Historical Sales by Application (2017-2022)
5.1.2 Global Oral Polio Vaccines (OPV) Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
5.2 Global Oral Polio Vaccines (OPV) Revenue by Application
5.2.1 Global Oral Polio Vaccines (OPV) Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Polio Vaccines (OPV) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
5.3 Global Oral Polio Vaccines (OPV) Price by Application
5.3.1 Global Oral Polio Vaccines (OPV) Price by Application (2017-2022)
5.3.2 Global Oral Polio Vaccines (OPV) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Polio Vaccines (OPV) Market Size by Type
6.1.1 North America Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
6.1.2 North America Oral Polio Vaccines (OPV) Revenue by Type (2017-2028)
6.2 North America Oral Polio Vaccines (OPV) Market Size by Application
6.2.1 North America Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
6.2.2 North America Oral Polio Vaccines (OPV) Revenue by Application (2017-2028)
6.3 North America Oral Polio Vaccines (OPV) Market Size by Country
6.3.1 North America Oral Polio Vaccines (OPV) Sales by Country (2017-2028)
6.3.2 North America Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Polio Vaccines (OPV) Market Size by Type
7.1.1 Europe Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
7.1.2 Europe Oral Polio Vaccines (OPV) Revenue by Type (2017-2028)
7.2 Europe Oral Polio Vaccines (OPV) Market Size by Application
7.2.1 Europe Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
7.2.2 Europe Oral Polio Vaccines (OPV) Revenue by Application (2017-2028)
7.3 Europe Oral Polio Vaccines (OPV) Market Size by Country
7.3.1 Europe Oral Polio Vaccines (OPV) Sales by Country (2017-2028)
7.3.2 Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Type
8.1.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Application
8.2.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Polio Vaccines (OPV) Market Size by Region
8.3.1 Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Polio Vaccines (OPV) Market Size by Type
9.1.1 Latin America Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
9.1.2 Latin America Oral Polio Vaccines (OPV) Revenue by Type (2017-2028)
9.2 Latin America Oral Polio Vaccines (OPV) Market Size by Application
9.2.1 Latin America Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
9.2.2 Latin America Oral Polio Vaccines (OPV) Revenue by Application (2017-2028)
9.3 Latin America Oral Polio Vaccines (OPV) Market Size by Country
9.3.1 Latin America Oral Polio Vaccines (OPV) Sales by Country (2017-2028)
9.3.2 Latin America Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Type
10.1.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Application
10.2.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country
10.3.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bibcol Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 Panacea Biotec Ltd
11.6.1 Panacea Biotec Ltd Corporation Information
11.6.2 Panacea Biotec Ltd Overview
11.6.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Panacea Biotec Ltd Recent Developments
11.7 Bio-Med
11.7.1 Bio-Med Corporation Information
11.7.2 Bio-Med Overview
11.7.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bio-Med Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bio-Med Recent Developments
11.8 Halfkin Bio-Pharmaceuticals
11.8.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.8.2 Halfkin Bio-Pharmaceuticals Overview
11.8.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Polio Vaccines (OPV) Industry Chain Analysis
12.2 Oral Polio Vaccines (OPV) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Polio Vaccines (OPV) Production Mode & Process
12.4 Oral Polio Vaccines (OPV) Sales and Marketing
12.4.1 Oral Polio Vaccines (OPV) Sales Channels
12.4.2 Oral Polio Vaccines (OPV) Distributors
12.5 Oral Polio Vaccines (OPV) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Polio Vaccines (OPV) Industry Trends
13.2 Oral Polio Vaccines (OPV) Market Drivers
13.3 Oral Polio Vaccines (OPV) Market Challenges
13.4 Oral Polio Vaccines (OPV) Market Restraints
14 Key Findings in The Global Oral Polio Vaccines (OPV) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Trivalent OPV
Table 3. Major Manufacturers of Bivalent OPV
Table 4. Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oral Polio Vaccines (OPV) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 7. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Table 8. Global Oral Polio Vaccines (OPV) Sales by Region (2023-2028) & (M Doses)
Table 9. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2023-2028)
Table 10. Global Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2017-2022)
Table 12. Global Oral Polio Vaccines (OPV) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region (2023-2028)
Table 14. Global Oral Polio Vaccines (OPV) Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Oral Polio Vaccines (OPV) Sales Share by Manufacturers (2017-2022)
Table 16. Global Oral Polio Vaccines (OPV) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oral Polio Vaccines (OPV) Revenue Share by Manufacturers (2017-2022)
Table 18. Oral Polio Vaccines (OPV) Price by Manufacturers (2017-2022) &(USD/Doses)
Table 19. Global Oral Polio Vaccines (OPV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Polio Vaccines (OPV) as of 2021)
Table 21. Oral Polio Vaccines (OPV) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oral Polio Vaccines (OPV) Product Offered
Table 23. Date of Manufacturers Enter into Oral Polio Vaccines (OPV) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 26. Global Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 27. Global Oral Polio Vaccines (OPV) Sales Share by Type (2017-2022)
Table 28. Global Oral Polio Vaccines (OPV) Sales Share by Type (2023-2028)
Table 29. Global Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Oral Polio Vaccines (OPV) Revenue Share by Type (2017-2022)
Table 32. Global Oral Polio Vaccines (OPV) Revenue Share by Type (2023-2028)
Table 33. Oral Polio Vaccines (OPV) Price by Type (2017-2022) & (USD/Doses)
Table 34. Global Oral Polio Vaccines (OPV) Price Forecast by Type (2023-2028) & (USD/Doses)
Table 35. Global Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 36. Global Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 37. Global Oral Polio Vaccines (OPV) Sales Share by Application (2017-2022)
Table 38. Global Oral Polio Vaccines (OPV) Sales Share by Application (2023-2028)
Table 39. Global Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Oral Polio Vaccines (OPV) Revenue Share by Application (2017-2022)
Table 42. Global Oral Polio Vaccines (OPV) Revenue Share by Application (2023-2028)
Table 43. Oral Polio Vaccines (OPV) Price by Application (2017-2022) & (USD/Doses)
Table 44. Global Oral Polio Vaccines (OPV) Price Forecast by Application (2023-2028) & (USD/Doses)
Table 45. North America Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 46. North America Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 47. North America Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 50. North America Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 51. North America Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 54. North America Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 55. North America Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Oral Polio Vaccines (OPV) Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oral Polio Vaccines (OPV) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oral Polio Vaccines (OPV) Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 108. Sanofi Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. GSK Corporation Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 113. GSK Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GSK Recent Developments
Table 115. Bibcol Corporation Information
Table 116. Bibcol Description and Major Businesses
Table 117. Bibcol Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 118. Bibcol Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bibcol Recent Developments
Table 120. Serum Institute Corporation Information
Table 121. Serum Institute Description and Major Businesses
Table 122. Serum Institute Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 123. Serum Institute Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Serum Institute Recent Developments
Table 125. Tiantan Biological Corporation Information
Table 126. Tiantan Biological Description and Major Businesses
Table 127. Tiantan Biological Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 128. Tiantan Biological Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Tiantan Biological Recent Developments
Table 130. Panacea Biotec Ltd Corporation Information
Table 131. Panacea Biotec Ltd Description and Major Businesses
Table 132. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 133. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Panacea Biotec Ltd Recent Developments
Table 135. Bio-Med Corporation Information
Table 136. Bio-Med Description and Major Businesses
Table 137. Bio-Med Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 138. Bio-Med Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Bio-Med Recent Developments
Table 140. Halfkin Bio-Pharmaceuticals Corporation Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 142. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2017-2022)
Table 143. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Polio Vaccines (OPV) Distributors List
Table 148. Oral Polio Vaccines (OPV) Customers List
Table 149. Oral Polio Vaccines (OPV) Market Trends
Table 150. Oral Polio Vaccines (OPV) Market Drivers
Table 151. Oral Polio Vaccines (OPV) Market Challenges
Table 152. Oral Polio Vaccines (OPV) Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Polio Vaccines (OPV) Product Picture
Figure 3. Global Oral Polio Vaccines (OPV) Market Share by Type in 2021 & 2028
Figure 3. Trivalent OPV Product Picture
Figure 4. Bivalent OPV Product Picture
Figure 5. Global Oral Polio Vaccines (OPV) Market Share by Application in 2021 & 2028
Figure 6. Public
Figure 7. Private
Figure 8. Oral Polio Vaccines (OPV) Report Years Considered
Figure 9. Global Oral Polio Vaccines (OPV) Sales 2017-2028 (M Doses)
Figure 10. Global Oral Polio Vaccines (OPV) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Oral Polio Vaccines (OPV) Revenue 2017-2028 (US$ Million)
Figure 12. Global Oral Polio Vaccines (OPV) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2017-2022)
Figure 14. Global Oral Polio Vaccines (OPV) Sales Market Share by Region (2023-2028)
Figure 15. North America Oral Polio Vaccines (OPV) Sales YoY (2017-2028) & (M Doses)
Figure 16. North America Oral Polio Vaccines (OPV) Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Oral Polio Vaccines (OPV) Sales YoY (2017-2028) & (M Doses)
Figure 18. Europe Oral Polio Vaccines (OPV) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Oral Polio Vaccines (OPV) Sales YoY (2017-2028) & (M Doses)
Figure 20. Asia-Pacific Oral Polio Vaccines (OPV) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Oral Polio Vaccines (OPV) Sales YoY (2017-2028) & (M Doses)
Figure 22. Latin America Oral Polio Vaccines (OPV) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Oral Polio Vaccines (OPV) Sales YoY (2017-2028) & (M Doses)
Figure 24. Middle East & Africa Oral Polio Vaccines (OPV) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Oral Polio Vaccines (OPV) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Oral Polio Vaccines (OPV) in the World: Market Share by Oral Polio Vaccines (OPV) Revenue in 2021
Figure 27. Global Oral Polio Vaccines (OPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 29. Global Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 30. Global Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 31. Global Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 32. North America Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 33. North America Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 34. North America Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 35. North America Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 36. North America Oral Polio Vaccines (OPV) Sales Share by Country (2017-2028)
Figure 37. North America Oral Polio Vaccines (OPV) Revenue Share by Country (2017-2028)
Figure 38. U.S. Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 41. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 42. Europe Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 43. Europe Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 44. Europe Oral Polio Vaccines (OPV) Sales Share by Country (2017-2028)
Figure 45. Europe Oral Polio Vaccines (OPV) Revenue Share by Country (2017-2028)
Figure 46. Germany Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 47. France Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Oral Polio Vaccines (OPV) Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Oral Polio Vaccines (OPV) Revenue Share by Region (2017-2028)
Figure 57. China Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 60. India Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 68. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 70. Latin America Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Oral Polio Vaccines (OPV) Sales Share by Country (2017-2028)
Figure 72. Latin America Oral Polio Vaccines (OPV) Revenue Share by Country (2017-2028)
Figure 73. Mexico Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Oral Polio Vaccines (OPV) Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Oral Polio Vaccines (OPV) Revenue Share by Country (2017-2028)
Figure 82. Turkey Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Oral Polio Vaccines (OPV) Revenue (2017-2028) & (US$ Million)
Figure 85. Oral Polio Vaccines (OPV) Value Chain
Figure 86. Oral Polio Vaccines (OPV) Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Industry Market Size
